1
|
Régnier JF, Imbert C, Boutonnet JC. Evaluation of the EYTEX® System as a Screening Method for the Ocular Irritancy of Chemical Products. Altern Lab Anim 2020. [DOI: 10.1177/026119299402200106] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The EYTEX® method is an in vitro test used to predict ocular irritation, based on alterations in a protein matrix. We have evaluated this method with the aim of using it to screen chemicals. One hundred and forty-two products (commodities and specialities), having a wide range of chemical properties and ocular irritation potential in the rabbit, were tested with either the standard, MPA, AMA, KMA or UMA protocols. The results were compared with in vivo data obtained previously for each chemical and with the EEC labelling of eye irritation for dangerous substances. Intralaboratory repeatability and interlaboratory reproducibility were evaluated with seven other laboratories. Ninety-three per cent of the chemicals tested were qualified with the EYTEX method. The coefficients of the linear correlation between the EYTEX score and the maximal Draize score on the one hand and the maximal corneal score on the other hand, were 0.69 and 0.65, respectively. Compared to the EEC classification, the labelling of dangerous substances and for the prediction of severe irritants, sensitivity, specificity and equivalence were 94%, 89% and 78%, respectively. We observed nine false positives (22%) and two false negatives (2%) for the identification of R41-, R34- and R35-labelled products. The predictive values, for identifying R41, R34 and R35 products and non-irritants or R36 products were 78% and 97%, respectively. Repeatability (6.3) and reproducibility (8.9) were quite satisfactory. The EYTEX system exhibits the characteristics of a good screening method: compatibility with a large range of chemicals; a simple and rapid procedure; good intralaboratory and interlaboratory reproducibility; cost effectiveness; high sensitivity, specificity and predictive value; and a low incidence of false negative and false positive results. Based on these results, we consider the EYTEX method to be a valuable tool for the screening of eye irritancy.
Collapse
Affiliation(s)
- Jean-François Régnier
- Elf Atochem s.a., Département de Toxicologic Industrielle, La Defense 10, Cedex 42, 92091 Paris la Defense, France
| | - Christophe Imbert
- Elf Atochem s.a., Centre d'Application de Levallois, BP 108,92300 Levallois Perret, France
| | - Jean-Charles Boutonnet
- Elf Atochem s.a., Centre d'Application de Levallois, BP 108,92300 Levallois Perret, France
| |
Collapse
|
2
|
Régnier JF, Imbert C. Contributions of Physicochemical Properties to the Evaluation of Ocular Irritation. Altern Lab Anim 2020. [DOI: 10.1177/026119299202000313] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
International guidelines for the evaluation of ocular irritation advise that all the available information, structural and physicochemical, should be taken into account in order to minimise the testing of substances under conditions that are likely to produce severe reactions in laboratory animals. In order to determine whether the pH and the acidic/alkaline reserve would be suitable parameters for the prediction of ocular irritation, we have measured, under standard conditions, the pH and the acidic/alkaline reserve of 166 chemicals (90 non-irritant, 22 irritant, and 54 severely irritant for the eye, according to the EEC classification and labelling system). The combination of these parameters permitted the correct identification of 74% of the severely irritant chemicals and 97% of the non-severely irritant (non-irritant or irritant) chemicals. The predictive value for a severely irritant potential was 93%, and 88% for non-severely irritant chemicals. This physicochemical approach, used as a first line screen for ocular irritation, is very simple and inexpensive.
Collapse
Affiliation(s)
- Jean-François Régnier
- Elf Atochem S.A., Départementde Toxicologie, 92091 Paris la Défense, Cedex 42, France; Elf Atochem S.A., BP 108
| | | |
Collapse
|
3
|
Rodríguez-Farré E, Roberfroid M, Fracchia GN. Research and Development of In Vitro Pharmacotoxicology: A European Perspective. Altern Lab Anim 2020. [DOI: 10.1177/026119299302100224] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The experts taking part in the Workshop were: E. Rodríguez-Farré ( Coordinator); G.N. Fracchia, (Secretary); M. Adolphe, École des Hautes Études, Paris, France); P.H. Bach (University of East London, UK); M. Baeder (Hoechst Ltd, Hattersheira, Germany); R. Bass (BGA, Berlin, Germany); H.G. Baumgarten (Frei Universität, Berlin, Germany); H. Bazin (DGXII, CEC, Brussels, Belgium); P. Bentley (Ciba-Geigy, Basle, Switzerland); A. Boobis (Royal Postgraduate Medical School, London, UK); J. Castell (Hospital La Fé, Valencia, Spain); J.P. Contzen (DGXII, CEC, Brussels, Belgium); A. Cordier (Sandoz Pharma Ltd, Basle, Switzerland); J. Diezi (Université de Lausanne, Switzerland); L. Dubertret (INSERM U-312, Creteil, France); P.M. Fasella (DGXII, CEC, Brussels, Belgium); J.H. Fentem (FRAME, Nottingham, UK); A. Guillouzo (INSERM U-49, Rennes, France); I. Kimber (Zeneca, Macclesfield, UK); T. Krieg (Universität zu Koln, Germany); A. Mantovani (Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy); K. Miller (BIBRA, Carshalton, UK); J.P. Morin (INSERM U-295, Rouen, France); D. Paul (Fraunhofer Institut für Toxikologie und Aerosolforschung, Hannover, Germany); P.W.J. Peters (Riijkinstituut voor Volksgezondheid en Milieuhygiene, Bilthoven, The Netherlands); J. Picard (Faculté des Sciences, Louvain la Neuve, Belgium); D. Poggiolini (Ministry of Health, Rome, Italy); C.M. Regan (University College, Dublin, Ireland); C.A. Reinhardt (SIAT, Zurich, Switzerland); B. Robaire (McGill University, Montreal, Canada); M. Roberfroid (Université Catholique de Louvain, Brussels, Belgium); V. Rogiers (Vrije Universiteit Brussels, Belgium); J. Rueff (Istituto de Higiene e Medicina Tropical, Lisbon, Portugal); H. Spielmann (ZEBET, Berlin, Germany); H. Stolte (Medizinische Hochschule, Hannover, Germany); J. van Noordwijk (European Pharmacopeia Commission, Bosch en Duin, The Netherlands); E. Walum (University of Stockholm, Sweden); D.C. Williams (Trinity College, Dublin, Ireland); and M. Yaniv (Institut Pasteur, Paris, France), and their contributions are gratefully acknowledged.
Collapse
Affiliation(s)
- Eduardo Rodríguez-Farré
- Department of Pharmacology and Toxicology, Consejo Superior de Investigaciones Científicas, c/Jorge Girona Salgado 18-26, E-08034 Barcelona, Spain
| | - Marcel Roberfroid
- Unité de Biochimie Toxicologique et Cancérologique, Université Catholique de Louvain, Avenue E. Mounier 73, B-1200 Brussels, Belgium
| | - Giovanni N. Fracchia
- Division of Medical Research, DGXII, Commission of the European Communities, Rue de la Loi 200, B-1049 Brussels, Belgium
| |
Collapse
|